If you are displaced or affected by wildfire, all Washington Apple Health and PEBB/SEBB medical plans are allowing prescription refills before the refill date.
Due to COVID-19, HCA’s lobby is closed. Learn more about your customer service options.

Meetings and materials

The P&T Committee / DUR Board meet at least quarterly. All meetings are open to the public.

Meetings and materials: Pharmacy and Therapeutic (P&T) Committee/Drug Utilization Review (DUR) Board

Upcoming meetings

December 16, 2020

Materials

Drug class reports will be taken down 30 days after the meeting.

Date	General Documents	P&T Documents	DUR Documents
October 21, 2020 WEBINAR ONLY	Agenda (10/21/2020) GoTo meeting registration	Multiple Sclerosis report	Drug class addendum
August 19, 2020 WEBINAR ONLY	Agenda (08/19/2020) Recorded webinar Transcript (08/19/2020)	CGRP report CGRP motion	Drug class motions Policy motions Drug class reviews Tyrosine kinase policy Hormone therapy policy Vraylar policy Cytokine & CAM policy Acute CGRP policy CGRP treatment policy Gout policy Drug class addendum
June 17, 2020 WEBINAR ONLY	Agenda (06/17/2020) Recorded webinar Transcript (06/17/2020)	TIMs motion	Drug class reviews Drug class addendum Drug class motions Policy motions Policy-ophthalmic agents Policy-oncology Policy-endocrine Revcovi Policy-endocrine Crysvita Policy-androgenic agents Policy-agents for ALS
April 15, 2020 MEETING CANCELED
February 19, 2020	Agenda (02/19/2020) Transcript (02/19/2020)	DPP4 inhibitors motion GLP1 agonists motion SGLT2 inhibitors motion	Drug class reviews and motions

Meeting details

All P&T Committee/DUR Board meetings are open to the public.
Directions to The Conference Center in Sea-Tac airport.
Sign up at the meeting to testify on a drug class. Stakeholder sign-up sheets are located in the lobby.
Stakeholders will be allowed three minutes for comments.
If you would like to give testimony, but cannot attend a meeting, please email a two-page maximum letter to Leta Evaskus at least one week before the meeting. She will put your testimony in the P&T Committee binders. If your testimony is longer than two pages, contact Leta for an address to mail it to.
Committee discussion and motions follow stakeholder comments.
Meetings are sponsored by the Health Care Authority and meet requirements of the Americans with Disabilities Act. Please call our ADA Coordinator at 360-725-9976 to make a request for special accommodations. TRS users may call this number through the Washington Relay Service by dialing 711.

Medicaid supplemental rebates

Effective January 1, 2018 HCA joined The Optimal PDL Solution (TOP$) supplemental rebate pool administered by Provider Synergies, a subsidiary of Magellan Medicaid Administration, LLC.

Please refer to the TOP$ website for more information about contracting and submitting rebates.

For additional Medicaid questions, please send an email to Apple Health (Medicaid).